Visser, PJ, Reus, LM, Gobom, J, Jansen, I, Dicks, E, van der Lee, SJ, Tsolaki, M, Verhey, FRJ, Popp, J, Martinez-Lage, P, Vandenberghe, R, Lleo, A, Molinuevo, JL, Engelborghs, S, Freund-Levi, Y, Froelich, L, Sleegers, K, Dobricic, V, Lovestone, S, Streffer, J, Vos, SJB, Bos, I, Smit, AB, Blennow, K, Scheltens, P, Teunissen, CE, Bertram, L, Zetterberg, H, Tijms, BM. Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer's disease (vol 17, pg 1, 2022). Molecular Neurodegeneration. 2022; 17(1)DOI:10.1186/s13024-022-00540-0. PMID:35550177. IF:15.100(Q1/1D).

Illan-Gala, I, Nigro, S, VandeVrede, L, Falgas, N, Heuer, HW, Painous, C, Compta, Y, Marti, MJ, Montal, V, Pagonabarraga, J, Kulisevsky, J, Lleo, A, Fortea, J, Logroscino, G, Quattrone, A, Quattrone, A, Perry, DC, Gorno-Tempini, ML, Rosen, HJ, Grinberg, LT, Spina, S, La Joie, R, Rabinovici, GD, Miller, BL, Rojas, JC, Seeley, WW, Boxer, AL. Diagnostic Accuracy of Magnetic Resonance Imaging Measures of Brain Atrophy Across the Spectrum of Progressive Supranuclear Palsy and Corticobasal Degeneration. JAMA Network Open. 2022; 5(4)DOI:10.1001/jamanetworkopen.2022.9588. PMID:35486397. IF:13.800(Q1/1D).

Ruiz-Barrio, I, Horta-Barba, A, Illan-Gala, I, Kulisevsky, J, Pagonabarraga, J. Genotype-Phenotype Correlation in Progressive Supranuclear Palsy Syndromes: Clinical and Radiological Similarities and Specificities. Frontiers in Neurology. 2022; 13DOI:10.3389/fneur.2022.861585. PMID:35557621. IF:3.400(Q2/5D).

Gonzalez, AC, Irwin, DJ, Alcolea, D, McMillan, CT, Chen-Plotkin, A, Wolk, D, Sirisi, S, Dols-Icardo, O, Querol-Vilaseca, M, Illan-Gala, I, Santos-Santos, MA, Fortea, J, Lee, EB, Trojanowski, JQ, Grossman, M, Lleo, A, Belbin, O. Multimarker synaptic protein cerebrospinal fluid panels reflect TDP-43 pathology and cognitive performance in a pathological cohort of frontotemporal lobar degeneration. Molecular Neurodegeneration. 2022; 17(1)DOI:10.1186/s13024-022-00534-y. PMID:35395770. IF:15.100(Q1/1D).